Cargando…
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Various physiological processes involve appropriate tissue developmental process and homeostasis - the pathogenesis of several diseases connected with deregulatory apoptosis process. Apoptosis plays a crucial role in maintaining a balance between cell death and division, evasion of apoptosis results...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664112/ https://www.ncbi.nlm.nih.gov/pubmed/31380246 http://dx.doi.org/10.15171/apb.2019.024 |
_version_ | 1783439840483737600 |
---|---|
author | Jan, Rehmat Chaudhry, Gul-e-Saba |
author_facet | Jan, Rehmat Chaudhry, Gul-e-Saba |
author_sort | Jan, Rehmat |
collection | PubMed |
description | Various physiological processes involve appropriate tissue developmental process and homeostasis - the pathogenesis of several diseases connected with deregulatory apoptosis process. Apoptosis plays a crucial role in maintaining a balance between cell death and division, evasion of apoptosis results in the uncontrolled multiplication of cells leading to different diseases such as cancer. Currently, the development of apoptosis targeting anticancer drugs has gained much interest since cell death induced by apoptosis causes minimal inflammation. The understanding of complexities of apoptosis mechanism and how apoptosis is evolved by tumor cells to oppose cell death has focused research into the new strategies designed to induce apoptosis in cancer cells. This review focused on the underlying mechanism of apoptosis and the dysregulation of apoptosis modulators involved in the extrinsic and intrinsic apoptotic pathway, which include death receptors (DRs) proteins, cellular FLICE inhibitory proteins (c-FLIP), anti-apoptotic Bcl-2 proteins, inhibitors of apoptosis proteins (IAPs), tumor suppressor (p53) in cancer cells along with various current clinical approaches aimed to selectively induce apoptosis in cancer cells. |
format | Online Article Text |
id | pubmed-6664112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-66641122019-08-02 Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics Jan, Rehmat Chaudhry, Gul-e-Saba Adv Pharm Bull Review Article Various physiological processes involve appropriate tissue developmental process and homeostasis - the pathogenesis of several diseases connected with deregulatory apoptosis process. Apoptosis plays a crucial role in maintaining a balance between cell death and division, evasion of apoptosis results in the uncontrolled multiplication of cells leading to different diseases such as cancer. Currently, the development of apoptosis targeting anticancer drugs has gained much interest since cell death induced by apoptosis causes minimal inflammation. The understanding of complexities of apoptosis mechanism and how apoptosis is evolved by tumor cells to oppose cell death has focused research into the new strategies designed to induce apoptosis in cancer cells. This review focused on the underlying mechanism of apoptosis and the dysregulation of apoptosis modulators involved in the extrinsic and intrinsic apoptotic pathway, which include death receptors (DRs) proteins, cellular FLICE inhibitory proteins (c-FLIP), anti-apoptotic Bcl-2 proteins, inhibitors of apoptosis proteins (IAPs), tumor suppressor (p53) in cancer cells along with various current clinical approaches aimed to selectively induce apoptosis in cancer cells. Tabriz University of Medical Sciences 2019-06 2019-06-01 /pmc/articles/PMC6664112/ /pubmed/31380246 http://dx.doi.org/10.15171/apb.2019.024 Text en © 2019 The Author (s). http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers. |
spellingShingle | Review Article Jan, Rehmat Chaudhry, Gul-e-Saba Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics |
title | Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics |
title_full | Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics |
title_fullStr | Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics |
title_full_unstemmed | Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics |
title_short | Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics |
title_sort | understanding apoptosis and apoptotic pathways targeted cancer therapeutics |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664112/ https://www.ncbi.nlm.nih.gov/pubmed/31380246 http://dx.doi.org/10.15171/apb.2019.024 |
work_keys_str_mv | AT janrehmat understandingapoptosisandapoptoticpathwaystargetedcancertherapeutics AT chaudhrygulesaba understandingapoptosisandapoptoticpathwaystargetedcancertherapeutics |